Despite 40 years of research investigation the biologic role of alpha-fetop
rotein (AFP) is still largely unknown. As an oncofetal antigen it is believ
ed to serve an important role in carcinogenesis and normal development. Sin
ce the mid-1960's this tumor-associated fetal protein has been clinically u
seful as a birth defect screening agent and tumor marker. Despite extensive
description of the synthetic, structural, and physiochemical properties of
this 70-kDa glycoprotein, the functional capacity of this oncofetal protei
n has only been described by in vitro studies to date. Attention has largel
y focused on ligand carrier/transport functions, immunoregulation, growth r
egulatory properties, and transcriptional enhancement and/or suppression. T
he latter includes regeneration, differentiation, transformation and regene
ration in oncogenic and ontogenetic growth processes. Therefore, AFPs origi
nal conceptual role only as a fetal substitute for albumin is no longer ten
able.